The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes

Parasitology Today

Volumn 15, Issue 4, 1999, Pages 136-140

  Barrett, M P ^a   Fairlamb, A H ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANTITRYPANOSOMAL AGENT; ARSANILIC ACID; ARSPHENAMINE; DIAMIDINE DERIVATIVE; DIMINAZENE ACETURATE; EFLORNITHINE; MELAMINE; MELARSAMINE; MELARSENOXIDE; MELARSOPROL; NUCLEIC ACID BASE; ORGANOARSENIC DERIVATIVE; TRYPANOTHIONE; TRYPARSAMIDE;

AFRICAN TRYPANOSOMIASIS; CROSS RESISTANCE; DRUG MECHANISM; DRUG TARGETING; DRUG UPTAKE; HUMAN; NONHUMAN; NUCLEOTIDE TRANSPORT; REVIEW; TRYPANOSOMA;

ANIMALS; ARSENICALS; CATTLE; DRUG RESISTANCE; HUMANS; PENTAMIDINE; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; TRYPANOSOMIASIS, BOVINE;

PROTOZOA; TRYPANOSOMA;

EID: 0033119815     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(99)01414-3     Document Type: Review

References (51)

1. Pepin, J. and Milord, F. (1994) The treatment of human African trypanosomiasis. Adv. Parasitol. 33, 1-47
2. Kuzoe, F.A.S. (1991) Perspectives in research on and control of African trypanosomiasis. Ann. Trop. Med. Parasitol. 85, 33-41
3. Bacchi, C.J. et al. (1990) Differential susceptibility to DL-α-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense. Antimicrob. Agents Chemother. 34, 1183-1188
4. Bacchi, C.J. (1993) Resistance to clinical drugs in African trypanosomes. Parasitol. Today 9, 190-193
5. Ehrlich, P. (1956) in The Collected Papers of Paul Ehrlich. Volume I. Histology, Biochemistry and Pathology (Himmelweit, F., ed.), pp 596-618, Pergamon Press
6. Friedheim, E.A.H. (1949) Mel B in the treatment of human trypanosomiasis. Am. J. Trop. Med. Hyg. 29, 173-180
7. Pepin, J. et al. (1995) Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness. Trans. R. Soc. Trop. Med. Hyg. 89, 92-97
8. Raynaud, J.P., Sones, K.R. and Friedheim, E.A.H. (1989) A review of Cymelarsan - A new treatment proposed for animal trypanosomiasis due to T. evansi and other trypanosomes of the T. brucei group. Int. Sci. Council Tryp. Res. Control 115, 334-338
9. Berger, B.J. and Fairlamb, A.H. (1994) Properties of melarsamine hydrochloride (Cymelarsan) in aqueous solution. Antimicrob. Agents Chemother. 38, 1298-1302
10. Van Schaftingen, E., Opperdoes, F.R. and Hers, H. (1987) Effects of various metabolic conditions and of the trivalent arsenical melarsen oxide on the intracellular levels of fructose 2,6-bisphosphate and of glycolytic intermediates in Trypanosoma brucei. Eur. J. Biochem. 166, 653-661
11. Fairlamb, A.H., Henderson, G.B. and Cerami, A. (1989) Trypanothione is the primary target for arsenical drugs against African trypanosomes. Proc. Natl. Acad. Sci. U. S. A. 86, 2607-2611
12. Fairlamb, A.H., Smith, K. and Hunter, K.J. (1992) The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 53, 223-232
13. Cunningham, M.L., Zvelebil, M.J.J.M. and Fairlamb, A.H. (1994) Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals. Eur. J. Biochem. 221, 285-295
14. Sands, M., Kron, M.A. and Brown, R.B. (1985) Pentamidine: A review. Rev. Infect. Dis. 7, 625-634
15. Peregrine, A.S. and Mamman, M. (1993) Pharmacology of diminazene: A review. Acta Trop. 54, 185-203
16. Shapiro, T.A. (1993) Inhibition of topoisomerases in African trypanosomes. Acta Trop. 54, 251-260
17. 2+ pump in plasma-membrane vesicles from Trypanosoma brucei: Selective inhibition by pentamidine. Biochem. J. 296, 759-763
18. Bitonti, A.J., Dumont, J.A. and McCann, P.P. (1986) Characterization of Trypanosoma brucei brucei S-adenosyl-L-methionine decarboxylase and its inhibition by Berenil, pentamidine and methylglyoxal bis(guanylhydrazone). Biochem. J. 237, 685-689
19. Berger, B.J., Carter, N.S. and Fairlamb, A.H. (1993) Polyamine and pentamidine metabolism in African trypanosomes. Acta Trop. 54, 215-224
20. Damper, D. and Patton, C.L. (1976) Pentamidine transport in Trypanosoma brucei -kinetics and specificity. Biochem. Pharmacol. 25, 271-276
21. Berger, B.J., Carter, N.S. and Fairlamb, A.H. (1995) Characterisation of pentamidine-resistant Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 69, 289-298
22. Carter, N.S., Berger, B.J. and Fairlamb, A.H. (1995) Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J. Biol. Chem. 270, 28153-28157
23. Williamson, J. and Rollo, I.M. (1959) Drug resistance in trypanosomes; cross-resistance analyses. Br. J. Pharmacol. 14, 423-430
24. Zhang, Z.Q., Giroud, C. and Baltz, T. (1991) In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium. Acta Trop. 50, 101-110
25. Fairlamb, A.H. et al. (1992) Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Mol. Biochem. Parasitol. 53, 213-222
26. Zhang, Z.Q., Giroud, C. and Baltz, T. (1993) Trypanosoma evansi: In vivo and in vitro determination of trypanocide resistance profiles. Exp. Parasitol. 77, 387-394
27. Pospichal, H. et al. (1994) Induction of resistance to melarsenoxide cysteamine (Mel Cy) in Trypanosoma brucei brucei. Acta Trop. 58, 187-197
28. Ross, C.A. and Barns, A.M. (1996) Alteration to one of three adenosine transporters is associated with resistance to cymelarsan in Trypanosoma evansi. Parasitol. Res. 82, 183-188
29. Scott, A.G., Tait, A. and Turner, C.M.R. (1997) Trypanosoma brucei: Lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites. Exp. Parasitol. 86, 181-190
30. Hawking, F. (1938) Analysis of the trypanocidal action of trivalent arsenicals and acriflavine. Ann. Trop. Med. Parasitol. 32, 313-331
31. Williamson, J. (1959) Drug resistance in trypanosomes; selective interference with trypanocidal action. Br. J. Pharmacol. 14, 431-442
32. Meshnick, S.R., Chang, K-P. and Cerami, A. (1977) Heme lysis of the bloodstream forms of Trypanosoma brucei. Biochem. Pharmacol. 26, 1923-1928
33. Carter, N.S. and Fairlamb, A.H. (1993) Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature 361, 173-176
34. Bacchi, C.J. et al. (1983) in Advances in Polyamine Research (Vol. 4) (Bachrach, U., Kaye, A. and Chayen, R., eds), pp 221-231, Raven Press
35. Barrett, M.P. et al. (1995) A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity. Mol. Biochem. Parasitol. 73, 223-229
36. Scott, A.G., Tait, A. and Turner, C.M.R. (1996) Characterization of cloned lines of Trypanosoma brucei expressing stable resistance to MelCy and suramin. Acta Trop. 60, 251-262
37. Gottesman, M.M. and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427
38. Borst, P. and Ouellette, M. (1995) New mechanisms of drug resistance in parasitic protozoa. Annu. Rev. Microbiol. 49, 427-460
39. Ullman, B. (1995) Multidrug resistance and P-glycoproteins in parasitic protozoa. J. Bioenerg. Biomembr. 27, 77-84
40. Maser, P. and Kaminsky, R. (1998) Identification of three ABC transporter genes in Trypanosoma brucei spp. Parasitol. Res. 84, 106-111
41. Dallagiovanna, B., Gamarro, F. and Castanys, S. (1996) Molecular characterization of a P-glycoprotein-related tcpgp2 gene in Trypanosoma cruzi. Mol. Biochem. Parasitol. 75, 145-157
42. Callahan, H.L. and Beverley, S.M. (1991) Heavy metal resistance: A new role for P-glycoproteins in Leishmania. J. Biol. Chem. 266, 18427-18430
43. Dey, S. et al. (1994) High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. Mol. Biochem. Parasitol. 67, 49-57
44. Papadopoulou, B. et al. (1994) Contribution of the Leishmania P-glycoprotein-related gene ltpgpa to oxyanion resistance. J. Biol. Chem. 269, 11980-11986
45. Mukhopadhyay, R. et al. (1996) Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proc. Natl. Acad. Sci. U. S. A. 93, 10383-10387
46. Légaré, D. et al. (1997) Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania. Exp. Parasitol. 87, 275-282
47. Dey, S. et al. (1996) An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae. Proc. Natl. Acad. Sci. U. S. A. 93, 2192-2197
48. Yarlett, N. et al. (1991) Differential susceptibility of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals. Exp. Parasitol. 72, 205-215
49. de Koning, H.P. and Jarvis, S.M. (1997) Purine nucleobase transport in bloodstream forms of Trypanosoma brucei brucei is mediated by two novel transporters. Mol. Biochem. Parasitol. 89, 245-258
50. Fairlamb, A.H. and Le Quesne, S.A. (1997) in Trypanosomiasis and Leishmaniasis: Biology and Control (Hide, G. et al., eds), pp 149-161, CAB International
51. Tye, C-K. et al. (1998) An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes. Bioorg. Med. Chem. Lett. 8, 811-816